Asia-Pacific ECMO Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia-Pacific ECMO Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia-Pacific ECMO Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia-Pacific ECMO Market Regional Analysis

6.2 Asia-Pacific ECMO Market Revenue 2020-2028 (US$ Million)

6.3 Asia-Pacific ECMO Market Forecast Analysis

7. Asia-Pacific ECMO Market Analysis – by Modality

7.1 Venoarterial ECMO

7.1.1 Overview
7.1.2 Venoarterial ECMO: Asia-Pacific ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Venovenous ECMO

7.2.1 Overview
7.2.2 Venovenous ECMO: Asia-Pacific ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Arteriovenous ECMO

7.3.1 Overview
7.3.2 Arteriovenous ECMO: Asia-Pacific ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Asia-Pacific ECMO Market Analysis – by Application

8.1 Respiratory

8.1.1 Overview
8.1.2 Respiratory: Asia-Pacific ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Cardiology

8.2.1 Overview
8.2.2 Cardiology: Asia-Pacific ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Asia-Pacific ECMO Market Analysis – by Age Group

9.1 Adults

9.1.1 Overview
9.1.2 Adults: Asia-Pacific ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Pediatrics

9.2.1 Overview
9.2.2 Pediatrics: Asia-Pacific ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Neonates

9.3.1 Overview
9.3.2 Neonates : Asia-Pacific ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Asia-Pacific ECMO Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia-Pacific ECMO Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 Asia-Pacific ECMO Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 China: Asia-Pacific ECMO Market Breakdown, by Modality
10.2.1.1.2 China: Asia-Pacific ECMO Market Breakdown, by Application
10.2.1.1.3 China: Asia-Pacific ECMO Market Breakdown, by Age Group

10.2.1.2 India: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 India: Asia-Pacific ECMO Market Breakdown, by Modality
10.2.1.2.2 India: Asia-Pacific ECMO Market Breakdown, by Application
10.2.1.2.3 India: Asia-Pacific ECMO Market Breakdown, by Age Group

10.2.1.3 Japan: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Japan: Asia-Pacific ECMO Market Breakdown, by Modality
10.2.1.3.2 Japan: Asia-Pacific ECMO Market Breakdown, by Application
10.2.1.3.3 Japan: Asia-Pacific ECMO Market Breakdown, by Age Group

10.2.1.4 Australia: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Australia: Asia-Pacific ECMO Market Breakdown, by Modality
10.2.1.4.2 Australia: Asia-Pacific ECMO Market Breakdown, by Application
10.2.1.4.3 Australia: Asia-Pacific ECMO Market Breakdown, by Age Group

10.2.1.5 Rest of Asia-Pacific : Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia-Pacific ECMO Market Breakdown, by Modality
10.2.1.5.2 Rest of Asia-Pacific : Asia-Pacific ECMO Market Breakdown, by Application
10.2.1.5.3 Rest of Asia-Pacific : Asia-Pacific ECMO Market Breakdown, by Age Group

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 ABIOMED Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Braile Biomedica

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Eurosets S.R.L.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Fresenius Medical Care AG & Co KGaA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Getinge AB

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 LivaNova Plc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Medtronic Plc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 MicroPort Scientific Corporation

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Nipro Medical Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Terumo Group

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia-Pacific ECMO Market

Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)